The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, longitudinal cohort study of approximately 59,000 non-users and users of tobacco products and those at risk for tobacco use across the United States. The sample will include approximately 42,000 adults 18 and up and 16,900 youth age 12-17. Survey data on tobacco use, attitudes, and health will be collected from adults, youth, and parents of youth and biospecimens (buccal cell, urine, and blood) will be collected from adults. PATH Study data will provide an evidence base for assessing and monitoring FDA’s current and future regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns. The PATH Study is conducted through an Interagency Agreement with the National Institute for Drug Abuse (NIDA) and the National Institutes for Health (NIH). <i>Information is current as of November 30, 2012.</i> ON TRACK NOT YET STARTED 1. Request for Proposal (RFP) awarded by NIDA-NIH to contractor 9/1/2011 Completed 9/1/2011 2. Develop draft survey instruments 7/1/2012 Completed 7/1/2012 3. Prepare and submit Office of Management and Budget (OMB) package for field test and main study Summer 2012 Completed 8/1/2012 4. Obtain OMB Approval for Field Test Fall 2012 Completed 11/1/2012 5. Launch Field Test Fall 2012/Winter 2013 Completed 12/5/2012 6. Complete Field Test analysis Winter/Spring 2013 Not Yet Started 7. Submit OMB materials for main study Summer 2013 Not Yet Started 8. Obtain OMB approval Summer 2013 Not Yet Started 9. Launch baseline data collection Fall 2013/Winter 2014 Not Yet Started 10. Complete data collection for baseline Fall 2014/Winter 2015 Not Yet Started 10. Complete data collection for baseline Fall 2014/Winter 2015 Not Yet Started 11. Launch first phase of follow up data collection Fall 2014/Winter 2015 Not Yet Started 12. Complete first manuscript of baseline results Fall 2015 Not Yet Started 13. Finalize restricted Use Data Set for baseline data Fall 2015 Not Yet Started 14. Complete first phase of follow up data collection Fall 2015/Winter 2016 Not Yet Started 15. Launch second phase of follow up data collection Fall 2015/Winter 2016 Not Yet Started 16. Publish First manuscript with first phase of follow up data Fall 2016 Not Yet Started 17. Finalize restricted Use Data Set from first phase of follow up data Fall 2016 Not Yet Started http://www.fda.gov/AboutFDA/Transparency/track/ucm252849.htm FDA-TRACK CTP Dashboard ਍††਍਍਍਍਍਍਍